Related Experiment Video
Updated: Jul 9, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Evaluation of non-uniform weighting in non-linear regression for pharmacokinetic neuroreceptor modelling
1Philips Research Europe, Aachen, Germany. frank.o.thiele@philips.com
Objective:
Pharmacokinetic modelling of dynamic PET data has become an important tool to analyse in-vivo studies in humans and animals. Estimation of the model parameters often requires non-linear regression of an objective function such as weighted least squares. Since the noise properties of the data are not known exactly in practice, several weighting schemes have been proposed. The objective of this study was to evaluate the impact of commonly used weights on neuroreceptor quantification with the simplified reference tissue model (SRTM).
Methods:
We compared the following weights: uniform, Poisson statistics-based ideal and noisy weights, iterative weighting, and a noise-free approximation of Poisson weights. Ten thousand time-activity curves (TACs) were simulated for several noise levels and the three neuroreceptor PET ligands C-(+)McN5652, C-DASB, and C-raclopride. Each TAC was fitted using weighted non-linear regression of the SRTM. We assessed bias and variation of the parameter estimates as well as quality of fit and parameter distributions.
Results:
Results differed substantially between ligands and between model parameters. Best parameter estimates were obtained with the noise-free approximation of Poisson weights. The often-used noisy Poisson weights performed worst for all ligands. Uniform weighting gave acceptable parameter estimates for most setups.
Conclusion:
'Choice of weights' is important in pharmacokinetic neuroreceptor quantification with the SRTM. Weights estimated directly from noisy data should be avoided as they can severely degrade parameter estimation and the statistical power of a study. If the noise characteristic of the data is unknown, uniform weighting is recommended.
Related Concept Videos
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
